RadioNano Therapeutics,Inc., a drug discovery venture originating from Kyoto University. We are focusing on boron neutron capture therapy (BNCT), an advanced radiation therapy that can selectively attack only cancer cells and has the potential to complete the treatment in a single session and a single day.
We are developing a new drug, RN-501, which will further advance BNCT by using nanoparticles to increase uptake into cancer tissue, aiming for safer and more effective treatment.
Address
Kyoto
Kyoto
Japan